Answers are grounded in this paper and cite their sources.
Background and Aim:The co-occurrence of herpes simplex encephalitis and COVID-19 presents a significant diagnostic and therapeutic challenge.This article reports a rare case of this dual infection and highlights the importance of timely diagnosis and treatment.Case Presentation: A 40-year-old woman with a history of hypertension presented to the emergency department with fever, headache, and two episodes of tonic-clonic seizures.Investigations revealed hypoxemia (SpO 2 =89%) and CT/MRI findings consistent with herpes encephalitis (bilateral temporal and frontal lobe lesions).A positive PCR test and pulmonary imaging confirmed concurrent COVID-19.Treatment with intravenous acyclovir, phenytoin, and supplemental oxygen led to complete clinical recovery within 72 hours.This case highlights three key points: the necessity of considering non-COVID etiologies for acute neurological symptoms in COVID-19 patients, the potential increased risk of HSV reactivation due to COVID-19-induced immune suppression or physiological stress, and the critical importance of empirical antiviral therapy before laboratory confirmation in suspected cases. Conclusion:Herpes simplex encephalitis should be included in the differential diagnosis of neurological manifestations in COVID-19 patients, particularly those presenting with seizures and altered consciousness.Rapid diagnostic evaluation and early treatment initiation can significantly improve clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Rezvan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: